Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
复制标题
DOI:
10.1016/j.bmc.2014.11.032
复制
发表时间:
2015-02
影响因子:
3.5
通讯作者:
Hai-Qiu Wu;Jin Yao;Qiu-Qin He;Wen‐xue Chen;Fener Chen;C. Pannecouque;E. De Clercq;D. Daelemans-D.-Daelema
中科院分区:
文献类型:
--
作者:
Hai-Qiu Wu;Jin Yao;Qiu-Qin He;Wen‐xue Chen;Fener Chen;C. Pannecouque;E. De Clercq;D. Daelemans-D.-Daelema
A series of new DAPY–DPEs hybrids, combined the important pharmacophores of DAPYs and DPEs, has been synthesized and biologically evaluated for their anti-HIV activities against wild-type HIV-1 strain IIIB, double RT mutant (K103N + Y181C) strain RES056 and HIV-2 strain ROD in MT-4 cell cultures. Many promising candidates with potent inhibitory activity (wild-type) within the EC50range from 0.16 to 0.013 μM were obtained. In particular,3c,3p,3rand3sdisplayed low nM level EC50values (35, 13, 50 and 17 nM, respectively) and high selectivity (9342, 25131, 2890 and 11338, respectively), which were much more potent than NVP (EC50= 0.31 μM, SI = 48), 3TC (EC50= 2.24 μM, SI > 39), DDI (EC50= 23.20 μM, SI > 9) and DLV (EC50= 0.65 μM, SI > 67), and comparable to AZT (EC50= 0.0071 μM, SI > 13144) and EFV (EC50= 0.0062 μM, SI > 1014). The HIV-1 reverse transcriptase inhibitory assay confirmed that these DAPY–DPEs hybrids targeted HIV-1 RT. Molecular simulation was performed to investigate the potential binding mode of the newly synthesized compounds. And reasonable explanation for the activity results was discussed with docking method.